Allison Q3 2026 results demonstrate strong organic growth and margin expansion, prompting raised guidance and challenging the previous WAIT stance.

What happened

Allison Transmission reported third quarter 2026 net sales of $1,534 million, a 121% year-over-year increase that includes the newly acquired Off-Highway business, while the core Allison Transmission segment posted a record $881 million in net sales, up 27% organically. Adjusted diluted EPS rose 59% to $2.90 on the back of higher volumes and disciplined execution, and adjusted EBITDA jumped 56% to $400 million with a 26.1% margin. Management raised full-year revenue, earnings, and cash flow guidance for the second consecutive quarter, signaling confidence in end-market strength and integration progress. The results directly address prior concerns about demand softness and synergy realization, as both top-line growth and profitability exceeded previous expectations. While the acquisition contributes significantly, the core business performance demonstrates robust underlying momentum.

Implication

Investors should recognize that Allison's organic growth and margin expansion are now outperforming the base-case assumptions from early 2026, reducing the risk that the Dana integration would mask underlying weakness. The core transmission business grew 27% organically with a record quarter, indicating pricing power and demand resilience that were previously in doubt. The raised guidance for the second consecutive quarter suggests management has visibility into sustained strength, not just a one-off quarter. However, the integration of Off-Highway still needs to demonstrate synergy realization beyond top-line contribution, and the company's higher capex and labor costs remain a drag on free cash flow. Given the improved fundamentals, the stock likely deserves a higher multiple, but valuation needs to be reassessed against the new earnings trajectory; a price near $125–130 may still offer upside relative to the updated guidance.

Thesis delta

The previous WAIT rating was predicated on unproven synergy cadence and cyclical uncertainty. Q3 2026 results materially exceed those assumptions, with the core business growing 27% organically and adjusted EPS up 59%, while management raised guidance for the second straight quarter. This shifts the balance of evidence toward a BUY, as the integration appears to be proceeding without disruption and end-market demand is stronger than anticipated. The main remaining risk is whether synergy targets are fully realized, but the core performance alone justifies a more constructive stance.